Know Labs wins new glucose monitoring patent

Seattle-based Know Labs has announced that it has received a new patent equating its diagnostic technology to the current glucose monitoring (CGM) standard.

Know Labs has developed Bio-RFID technology which uses spectroscopy to direct electromagnetic energy through a substance or material to capture a unique molecular signature. It is then integrated into wearable, mobile or bench-top format, and the first application of the technology is in the form of a non-invasive glucose monitor.

The company’s technology claims to have a range of clinical accuracy that is equal or superior to that of any FDA-cleared blood glucose monitoring products. It enables the collection of a “massive amount” of data signals across interstitial fluid, capillary and venous blood and cellular tissue. Its sensor penetrates to an average of 0.5 inches, compared to the typical penetration of 0.2 inches with common minimally invasive CGMs.

The company believes that this non-invasive technology could “become the new reference standard for glucose testing.”

To read more, CLICK HERE.

Desang Diabetes Magazine is our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it really is free, and you can easily unsubscribe should you wish to).

Sign me up!
Open publication
Buy a Desang kitbag

See our range of kitbags